Predictors of long-term beneficial effects on blood pressure after percutaneous transluminal renal angioplasty in atherosclerotic renal artery stenosis

International Angiology

Volumn 28, Issue 2, 2009, Pages 106-112

  Alhadad, A ^a   Mattiasson, I ^a   Ivancev, K ^a   Lindblad, B ^a   Gottsater A ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Angioplasty, balloon; Hypertension; Renal artery obstruction

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST;

AGED; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC RENAL ARTERY STENOSIS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CHOLESTEROL EMBOLISM; CLINICAL EVALUATION; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DYING; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; KIDNEY INFARCTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERCUTANEOUS TRANSLUMINAL RENAL ANGIOPLASTY; POSTOPERATIVE HEMORRHAGE; PREDICTOR VARIABLE; REDUCTION; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; CHI SQUARE DISTRIBUTION; COMPLICATION; DRUG EFFECTS; HYPERTENSION, RENOVASCULAR; MIDDLE AGED; PATHOPHYSIOLOGY; RENAL ARTERY OBSTRUCTION; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; SWEDEN; TIME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ATHEROSCLEROSIS; BLOOD PRESSURE; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS; DIURETICS; FEMALE; HUMANS; HYPERTENSION, RENOVASCULAR; LOGISTIC MODELS; MALE; MIDDLE AGED; RENAL ARTERY OBSTRUCTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SWEDEN; TIME FACTORS; TREATMENT OUTCOME;

EID: 67650432940     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Vaughan ED Jr. Renovascular hypertension. Kidney Int 1985;27:811-827
2. Textor SC, Novick AC, Tarazi RC, Klimas V, Vidt DG, Pohl M. Critical perfusion pressure for renal function in patients with bilateral atherosclerotic renal vascular disease. Ann Intern Med 1985;102:308-314 (Pubitemid 15101858)
3. Ramsay LE, Waller PC. Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: an overview of published series. BMJ 1990;300:569-572 (Pubitemid 20090271)
4. Martin LG, Rundback JH, Sacks D, Cardella JF, Rees CR, Matsumoto AH et al. Quality improvement guidelines for angiography, angioplasty, and stent placement in the diagnosis and treatment of renal artery stenosis in adult. J Vasc Interv Radiol 2002;13:1069-1083 (Pubitemid 35332891)
5. Van Jaarsveld BC, Krijnen P, Pieterman H, Derkx FH, Deinum J, Postma CT et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. N Engl J Med 2000;342:1007-1014 (Pubitemid 30180647)
6. Plouin PF, Chatellier G, Dame B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Hypertension 1998;31:823-9. (Pubitemid 28108582)
7. Webster J, Marshall F, Abdalla M, Dominiczak A, Edwards R, Isles CG et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 1998;12:329-335
8. Conlon PJ, Little MA, Pieper K, Mark DB. Severity of vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int 2001;60:1490-1497 (Pubitemid 32960044)
9. Johansson M, Herlitz H, Jensen G, Rundqvist B, Friberg P. Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens. J Hypertens 1999;17:1743-1750
10. Alhadad A, Ahle M, Ivancev K, Gottsäter A, Lindblad B. Percutaneous transluminal renal angioplasty (PTRA) and surgical revascularisation in renovascular disease. Retrospective comparison of results, complications, and mortality. Eur J Vasc Endovasc Surg 2004;27:151-156 (Pubitemid 38111681)
11. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 2002;346: 1945-1962 (Pubitemid 34651355)
12. Minuz P, Patrignani P, Gaino S, Degan M, Menapace L, Tommssoli R et al. Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Circulauon 2002;106:2800-2805 (Pubitemid 35396979)
13. Pizzolo F, Mansueto G, Minnid S, Mazzi M, Trabetti E, Girelli D et al. Renovascular disease: Effect of ACE gene deletion polymorphism and endovascular revascularization. J Vasc Surg 2004;39:140-147 (Pubitemid 38056164)
14. Alhadad A, Guron G, Fortuna-Nowakowska E, Mattiasson I, Jensen G, Lindblad B et al. Renal angioplasty causes a rapid transient increase in inflammatory biomarkers, but reduced levels of interleukin-6 and endothelin-1 1 month after intervention. J Hypertens 2007;25:1907-1914
15. Ceconi C, Fox KM, Remme WJ, Simoons ML, Bertrand M, Parrinello G et al. ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT. Cardiovasc Res 2007;73:237-246
16. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
17. Alhadad A, Mattiasson I, Ivancev K, Lindh M, Gottsäter A, Lindblad B. Mean pressure gradient in renal artery stenosis (RAS) before and after percutaneous transluminal renal angioplasty (PTRA) regarding initial effect and long-term outcome. Useful or not? J Renovasc Dis 2006;4:7-13.
18. Rundback JH, Sacks D, Kent KC, Cooper C, Jones D, Murphy T et al. Guidelines for the reporting of renal artery revascularization in clinical trials. J Vasc Interv Radiol 2002;13:959-974 (Pubitemid 35231852)
19. Nordmann AJ, Woo K, Parkes R, Logan AG. Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials. Am J Med. 2003;114:44-50. (Pubitemid 36126515)
20. The impact of renal artery revascularisation in atherosclerotic renovascular disease: The angioplasty and stenting for renal artery lesions (ASTRAL) trial. Oral presentation by Philip A. Kalra at the Society for Cardiovascular Angiography and Intervention (SCAI)-ACCi2 educational session, 2008 April 1; Chicago, IL, USA.
21. Isles CG, Robertson S, Hill D. Management of renovascular disease: a review of renal artery stenting in ten studies. Q J Med 1999;92:159-167 (Pubitemid 29116952)
22. Streeten DH, Anderson GH Jr, Wagner S. Effect of age on response of secondary hypertension to specific treatment. Am J Hypertens 1990;3:360-365 (Pubitemid 20188287)
23. Plouin PF. Stable patients with atherosclerotic renal artery stenosis should be treated first with medical management: PRO. Am J Kidney Dis 2003;42:851-857 (Pubitemid 37322903)
24. Losito A, Gaburri M, Errico R, Parente B, Cao PG. Survival of patients with renovascular disease and ACE inhibition. Clin Nephrol 1999;52:339-343
25. Perkovic V, Thomson KR, Becker GJ. Factors affecting outcome after percutaneous renal artery stent insertion. J Nephrol 2002;15:649-654 (Pubitemid 36040565)
26. Powell JS, Clozel JP, Muller RK, Kuhn H, Hefti F, Hosang M. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989;245:186-188 (Pubitemid 19193936)
27. Casas JP, Chua W, Loukogeorgakis S, Vallance P, Smeeth L, Hingorani AD et al. Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet 2005;366:2026-2033 (Pubitemid 41773378)
28. Hricik DE, Browning PJ, Kopelman R, Goorno WE, Madias NE, Dzau VJ. Captopril-induced functional renal insufficiency in patients with bilateral renal artery stenosis or renal artery stenosis in a solitary kidney. N Engl J Med 1983;308:373-376 (Pubitemid 13187219)
29. Curtis JJ, Luke RG, Whelchel JD, Diethelm AG, Jones P, Dustan HP. Inhibition of angiotensin converting enzyme in renal-transplant recipient with hypertension. N Engl J Med 1983;308:377-381 (Pubitemid 13187220)
30. Hollenberg NK. Renal hemodynamics in essential and renovascular hypertension: influence of captopril. Am J Med 1984;76:22-28 (Pubitemid 14106341)
31. Textor SC, Tarazi RC, Novick AC, Bravo EL, Fouad FM. Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril. Am J Med 1984;76:29-37. (Pubitemid 14106342)
32. Hall JE, Guyton AC, Jackson TE, Coleman TG, Lohmeier TE, Trippodo NC. Control of glomerular filtration rate by reninangiotensin system. Am J Physiol 1977;233:F366-F72. (Pubitemid 8240749)
33. Hall JE, Coleman TG, Guyton AC, Balfi JW, Salgado HC. Intrarenal role of angiotensin II and (des-Asp1)-angiotensin II. Am J Physiol 1979;236:F252-F9.
34. Ramos F, Kotliar C, Alvarez D, Baglivo H, Rafaelle P, Londero H et al. Renal function and outcome of PTRA and stenting for atherosclerotic renal artery stenosis. Kidney Int 2003;63:276-282
35. Haller C. Atherosclerotic renal artery stenosis: conservative versus interventional management. Heart 2002;88:193-197 (Pubitemid 34787785)
36. Plouin PF, Darne B, Chatellier G, Pannier I, Battaglia C, Raynaud A et al. Restenosis after percutaneous transluminal renal angioplasty. Hypertension 1993;21:89-96. (Pubitemid 23006457)
37. Jensen G, Zachrisson BF, Delin K, Volkman R, Aurell M. Treatment of renovascular hypertension: one year results of renal angioplasty. Kidney Int 1995;48:1936-1945
38. Derkx FH, Schalekamp MA. Renal artery stenosis and hypertension. Lancet 1994;344:237-239
39. Rimmer JM, Gennari FJ. Atherosclerotic renovascular disease and progressive renal failure. Ann intern Med 1993;118:712-719 (Pubitemid 23118044)
40. Semple PF, Dominiczak AF. Detection and treatment of renovascular disease: 40 years on. J Hypertens 1994;12:729-734 (Pubitemid 24243160)
41. Holm-Bentzen M, Gerstenberg T, Horn T, Larsen S. Medial fibroplasia: involvement of renal artery and small renal arteries in renal vascular hypertension. Scand J Urol Nephrol 1993;27:263-265 (Pubitemid 23188380)
42. Alhadad A, Mattiasson I, Ivancev K, Gottsäter A, Lindblad B. Revascularisation of renal artery stenosis caused by fibromuscular dysplasia: effects on blood pressure during 7-year follow-up are influenced by duration of hypertension and branch artery stenosis. J Human Hypertens 2005;19:761-767 (Pubitemid 41486138)
43. Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, Gebel MJ et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal artery stenosis. N Engl J Med 2001;344:410-417 (Pubitemid 32128673)
44. Henry M, Henry I, Klonaris C, Polydorou A, Rath P, Lakshmi G et al. Renal angioplasty and stenting under protection: the way for the future? Catheter Cardiovasc Interv 2003;60:299-312.
45. Holden A, Hill A, Jaff MR, Pilmore H. Renal artery stent revascularization with embolic protection in patients with ischemic nephropathy. Kidney Int 2006;70:948-955 (Pubitemid 44285973)
46. McDonald DN, Smith DC, Maloney MD. Percutaneous transluminal renal angioplasty in the patient with a solitary functioning kidney. AJR Am J Roentgenol 1988;151:1041-1043 (Pubitemid 18251592)
47. Morishita R, Higaki J, Miyazaki M, Ogihara T. Possible role of the renin-angiotensin system in hypertension and vascular hypertrophy. Hypertension 1992;2(Suppl 1):162-167
48. Alhadad A, Mattiasson I, Ivancev K, Gottsäter A, Lindblad B. Sustained beneficial effects on blood pressure during long time retrospective follow-up after endovascular treatment of renal artery occlusion. J Human Hypertens 2004;18:739-744 (Pubitemid 39369195)